Coronavirus: Hong Kong bans use of Pfizer Covid-19 Vaccine

New Delhi: The use of Pfizer-BioNtech's Corona vaccine has been stopped in Hong Kong on the basis of packaging malfunctions. Fosun Pharma, a vaccine-distributing company in Hong Kong, found a defect in the vial lid of a batch of vaccines. On this basis, its use is banned with immediate effect.

Hong Kong bans Pfizer vaccine:

According to the information, BioNotech and Fosun Pharma have not detected any type of malfunction in the vaccine. The packaging of batch number 210202 has been found to be defective. As a precaution, the use of Pfizer vaccine has been banned.

ALSO READ: AstraZeneca may have used ‘Old Data’ during vaccine trial: US Agency

"For the sake of precaution, the current vaccination must be suspended during the period of investigation,” the Hong Kong Government says.

At the same time, The US Health Agency suspects that the company used old data during the trial. Let us know that the day before, AstraZeneca has announced the results of the vaccine trial in America. Under this, it has been said that vaccine is 79% effective.

American Agency suspects the use of Astrazeneca:

According to the US National Institute of Allergy and Infectious Disease, the Data Safety Monitoring Board has raised concerns about AstraZeneca’s data. The board suspects that AstraZeneca used old data during the trial. So it is difficult to tell exactly how effective this vaccine is. The final decision on the use of this vaccine in America will be made by an Advisory Committee.

ALSO READ: New double mutant corona variant found in 18 Indian States

Andrew Pollard, a professor at the University of Oxford and principal investigator for vaccines, said, “The results are good news because it shows the vaccine’s impact.” It also looks equally effective in the outcome of the Oxford trial. ”

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.